Ongoing Positive Effect of Platelet-Rich Plasma Versus Corticosteroid Injection in Lateral Epicondylitis

Author: Gosens et al
Year: 2011

The Regenerative Clinic's view on this research

Mr Ali Noorani “A follow up study by the same group published in 2011 with the same patients with two years follow up2. They concluded that those patients with treated with corticosteroid returned back to base line whereas those treated with PRP continued to improve and maintained this improvement at 2 years. They concluded that treatment of patients with chronic lateral epicondylitis ( tennis elbow) with PRP reduces pain and increases function significantly, exceeding the effects of cortico steroid injections even after a follow up of two years.”

Abstract

Purpose: This trial was undertaken to determine the effectiveness of PRP compared with corticosteroid injections in patients with chronic lateral epicondylitis with a 2-year follow-up.

Study Design: Randomized controlled trial; Level of evidence, 1.

Methods: The trial was conducted in 2 Dutch teaching hospitals. One hundred patients with chronic lateral epicondylitis were randomly assigned to a leukocyte-enriched PRP group (n = 51) or the corticosteroid group (n = 49). Randomization and allocation to the trial group were carried out by a central computer system. Patients received either a corticosteroid injection or an autologous platelet concentrate injection through a peppering needling technique. The primary analysis included visual analog scale (VAS) pain scores and Disabilities of the Arm, Shoulder and Hand (DASH) outcome scores.

Results: The PRP group was more often successfully treated than the corticosteroid group (P \ .0001). Success was defined as a reduction of 25% on VAS or DASH scores without a reintervention after 2 years. When baseline VAS and DASH scores were compared with the scores at 2-year follow-up, both groups significantly improved across time (intention-to-treat principle). However, the DASH scores of the corticosteroid group returned to baseline levels, while those of the PRP group significantly improved (as-treated principle). There were no complications related to the use of PRP.

Conclusion: Treatment of patients with chronic lateral epicondylitis with PRP reduces pain and increases function significantly, exceeding the effect of corticosteroid injection even after a follow-up of 2 years. Future decisions for application of PRP for lateral epicondylitis should be confirmed by further follow-up from this trial and should take into account possible costs and harms as well as benefits.

https://www.ncbi.nlm.nih.gov/pubmed/21422467

Get in touch

Find your clinic

We offer appointments nationwide and now working with partners abroad providing cutting edge Regenerative Medicine to patients in UK, Italy, Australia, Spain and Pakistan.